The beneficial metabolic effects of Nrg4 were observed to be eliminated by anti-angiogenic drug treatment in another study (Nugroho et al., 2018b), suggesting that the angiogenic effect of Nrg4 was an essential strategy in preventing obesity (Figure 3). The gene discussed is NRG4; the disease is obesity due to melanocortin 4 receptor deficiency.